Jonathan focuses primarily on counseling and defending product liability actions against pharmaceutical and medical device manufacturers. He provides guidance and expertise on all aspects of the litigation process, including pre-litigation risk assessments, e-discovery issues, deposition preparation, company witness and expert development, trial strategy and settlement. He has assisted clients in formulating strategies on the risk posed by post-settlement liens and third-party payor actions. He also has experience counseling clients regarding federal regulations governing the pharmaceutical industry, the Medicare Secondary Payer Act, and Section 111 of the Medicare, Medicaid and SCHIP Extension Act of 2007.

Jonathan has significant experience in the collection, organization, analysis and production of client documents. He has managed large-scale document collections and reviews with the assistance of third-party document review service providers. His experience includes work on federal multidistrict litigation, state consolidated matters and individual state and federal cases.

Before joining Shook, Jonathan worked for Levine, Blaszak, Block & Boothby, where he practiced commercial litigation.  


Cary Silverman, Phil S. Goldberg and Jonathan L. Wilson, Torts of the Future: Addressing the Liability and Regulatory Implications of Emerging Technologies (U.S. Chamber Inst. for Legal Reform, March 2017).

Cary Silverman & Jonathan Wilson, State Attorney General Enforcement of Unfair or Deceptive Acts and Practices Laws: Emerging Concerns and Solutions, 65 Kan. L. Rev. 209 (2016).

Jonathan Wilson, Can a Copyright Holder Prevent Reverse Engineering? The Federal Circuit Court Holds that the Federal Copyright Act Does Not Preempt “No Reverse Engineering” Clauses. Bowers v. Baystate Tech. Inc., Computer Law Review and Technology Journal, Summer 2004.